{"name":"Mati Therapeutics Inc.","slug":"mati-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Latanoprost Punctal Plug Delivery System","genericName":"Latanoprost Punctal Plug Delivery System","slug":"latanoprost-punctal-plug-delivery-system","indication":"Treatment of glaucoma and ocular hypertension","status":"phase_2"}]}],"pipeline":[{"name":"Latanoprost Punctal Plug Delivery System","genericName":"Latanoprost Punctal Plug Delivery System","slug":"latanoprost-punctal-plug-delivery-system","phase":"phase_2","mechanism":"Latanoprost Punctal Plug Delivery System works by delivering latanoprost, a prostaglandin F2α analogue, directly to the eye to reduce intraocular pressure.","indications":["Treatment of glaucoma and ocular hypertension"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5gJBVV95cUxOU0lLeHFHSjZLbnVoeDJyY3dZeWVBRmpOTGVoUGxKZDJfVVJKVjh2elhTQ1RLQnEyV2dOb05ZbThpUzFZQm1iTjVpXzVDR09JTDM1WS0wTENSdGhIZmpjbXJuYnNXbWNQVFJKMHM1dlAzRXhhUjdvaVZSX0R3YUlva1NURUk1UVV3OGVwc3l2akhNTmxJYWtsZjRCaS1YRk9kMWtZVTRhSnJIOXJYNlhEUjVxXzlITmhoWmJsMDhhakE4alBoLVFjM1hhOVNDVlY2UmkxeWhSc3h4RmktMldMdTdlMFF5cnkxSVJrQ0M5ZkJNOHZwRkxEbEVBMFFtdjRqbXpvRjI1encxWlh6Y3BubFpuQktOb1Q0YUppc0FpTlo1MWt3YmNENHdFY2x2QkFELWEtX3NjenRvR1Zjd0VPMFdBeG5wRWt1UmhGV2hvRU9kbUdmNHlXU2RhN0g2Zndzc3dkWmtn?oc=5","date":"2026-03-04","type":"pipeline","source":"GlobeNewswire","summary":"Ophthalmic Drug Delivery System Market Research Report - GlobeNewswire","headline":"Ophthalmic Drug Delivery System Market Research Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPbTQ4dFNtN3ZWMHZHY1NwMmgzbVZvVzF0VElQNWVWWXVHQ1BjTXIxTmQ4VWY4RGdfVlFVYkU0LVBPbHZJQThMQmRHRGFYc19yYXZOeFJVSjh2UFNoR2hfT0tHZmZYdmdpVDJlOWtnQklZSERqdWxidWtvVjJCLWQyMVladEh4b0hsZ0lXZGRkWXFsc1FLU1hjWkdDdmx3WmNSQ0FfT1FGcmIxejI3Rnk3LWpCbm8yNS0xQmUtVFRsajhtTHdrWkZ6S3gwNTNxd1cxTkE3RWZnS2t6V3FLY2FUN2JQbGRrVWlMY1kzRkdRcUVVMms3WUhPQnhCbkwzeWxsRnFva0oyVEVjdUx6ZTAycFBQakh0dXVSRENRb2hfTjBoNEtUOTZGdGtNem5nemJBaEQ0elRhT245eG9H?oc=5","date":"2026-01-28","type":"trial","source":"GlobeNewswire","summary":"Chronic and Acute Pain Clinical Trial Pipeline Analysis: - GlobeNewswire","headline":"Chronic and Acute Pain Clinical Trial Pipeline Analysis:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNMVY2VXIyY2ZsdnBLVjJZTDdJRTFubUtHazBiYXJsaldqQ19KRW5zNWlCZmtsRExBdXV4OEFRNHlFXzFzVF9YQnh6eE02R3Z3MjJWdXVrVFNPM1JnYkJHdE1nYU8wZWlZMTNGSGNuUTFKck5DWEJCd0hfNWJVQmRVakFBZHpBUDRIbEdvMk1fcEpreVNxQXR6OHpuN3lkenFpOGVyaTlQMjhhNjhUTl81NWoxRQ?oc=5","date":"2026-01-22","type":"deal","source":"MobiHealthNews","summary":"Q&A: Insitro acquires CombinAble.AI, marking first Israeli exit for AI pharma startup - MobiHealthNews","headline":"Q&A: Insitro acquires CombinAble.AI, marking first Israeli exit for AI pharma startup","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxOa28xYl9RVE1GOS1IblJOR1dEYTZGcFdIOFNhU3V3QTZhS0lFVXRVNFM5MXdQalMyWnVWUmhzQzQyN2E1WW9IWHlwUWY0ZzhGZmUxNnVSNldYWDJJUlJZUkJhOXlJOFoxM0owd0xQdHB4dGUwdlBENS0xYXpfWWxhelExaW9scDczaktaV3dfekVpOG16bXNLNWttSzNrMFNfWXpGd2dNYkVSbXdNMGplZFlIQURBcmFxV2FPdmNrOTVlZVNUZFNYR3luZERqRzVYQ3NIcEJuT0F5Z0tobXFpZ3BBZWlOLVNwR0lGWHg0WjlmdU9KTlI1cTFzbUlqRFhsdDZrSEZSUFVrMDhXSXNhdjJiRzYzVnBTZHljUnN3?oc=5","date":"2025-10-29","type":"pipeline","source":"PR Newswire","summary":"Postoperative Ileus Market to Advance Moderately During the Forecast Period (2025-2034) Owing to the Launch of Novel Therapies | DelveInsight - PR Newswire","headline":"Postoperative Ileus Market to Advance Moderately During the Forecast Period (2025-2034) Owing to the Launch of Novel The","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxOUmQybk9TX2VZZTFLQVZuek1GNl9ZdUU2eFlSZTdVTWpqZEtLU3M2MnRVLURYT0VfWVFBMk95YTZEOHF0ZHhDZmFIcU0yWHBQUWY3TTQybWFVWmUyMkNBdlNGZ3l0TzhOSUJwZklSd0VONXFLd3RTSER4dDV5T1lkeUNrYnM4NTZzb1ZzVUFualNPV25vSXRIaXU4U2l4YjVkQUlQeE5MeWtpd3FqaHk4TVJwVWYyRS0yb0piNU9vZ2ZFUG1zdTJCWEdYbG1nQW1PNW9CWF9fWkEyY1Nwek9IenlzcERnTk96SzNxOWdvSDVGeUFXOXdZRFRrcndESU01SkNPMVN3X1pmQnQ5V1A1WllCaUhrRzJLSHVTdTY0cF80QQ?oc=5","date":"2025-09-24","type":"trial","source":"PR Newswire","summary":"Moderate-to-Severe Acute Pain Market Anticipates Impressive Growth Trajectory at a CAGR of 14% During the Study Period (2020-2034) | DelveInsight - PR Newswire","headline":"Moderate-to-Severe Acute Pain Market Anticipates Impressive Growth Trajectory at a CAGR of 14% During the Study Period (","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxPOFpISUVmRloyZnR4c0dVT25yNVUxS2Frc3U3WHc2d3pxUzEtdmtxRDZWb1gyUUphc1pCSERPMHA3TnkyZlBuRmdHWGNScDJ4OFFDaW1rMHQzWjZFSksxZlQ3YjM0QVl2aHA5ZWJBNjdYdHNrZVZMUWxCSlpZYkJBV1JTZ01lMHZvVXQ2dVYtSnZUZ1hJTWtLSzlMOFlBTEJtTGRoTVRZNFRtTG5QckVzbFVKZG1WTXY1NHRuMXNxc09jV0FfRFV6M1llaDVWSEtWSzVvQzNrSXBMQmZHODBkZ1ZYSEtwVHBhQWkxZVJKVmhVTHNWNm5mYUlMdWNqZHNxaFdaUmhJWG82bUI3elM1NjhmZmJ1S2VX?oc=5","date":"2025-06-16","type":"pipeline","source":"PR Newswire","summary":"Chronic Lower Back Pain Market to Expand Significantly During the Forecast Period (2025-2034) with Game-Changing Therapies | DelveInsight - PR Newswire","headline":"Chronic Lower Back Pain Market to Expand Significantly During the Forecast Period (2025-2034) with Game-Changing Therapi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxQMHhfSGI1a3NjMkNsRC1ZdkRNUzJnS0FnMkhZbFBiRWF2Ykp0cHlVQ3IyZVRsZWNQQjNEaW5ESUd5V0ktU3NYYnI4NHAxT0tDLVFQZ0dDMlhyekNqZzI4RnRhX3FXV3VnX1VFODIwMkRvdUwxMEJqRlBjNnkwRktlODhwSEJOWEVVaERzXzlPTGdpSDNITmpFWXdjYldwUHkwWXVldjZXSkp6N3lZWC1LOEtqOGJRY05NdU52V1JFejhKX1BFS3NXRG1wd0NnckxyNmdIRWxoUGVnalJOeWp3Rl9TaDNHYThTOHc?oc=5","date":"2025-03-25","type":"pipeline","source":"PR Newswire","summary":"ROCKLATAN/ROCLANDA Strengthens Market Position with Robust Sales and Patient Outcomes | DelveInsight - PR Newswire","headline":"ROCKLATAN/ROCLANDA Strengthens Market Position with Robust Sales and Patient Outcomes | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxONzJwRzBpN1dGQ1h1QkRLdEFDQnRrcTJhMUkwSTJRdk9uZWJkVUZOd2VNel8tTWlJYzZkSzdJSG9nRXRuZFpkVFpEV1RKMDBvTWlkNnRaN3BzVUU5SWdZZDVwc1djWWhEaVhPRjlxWS15RDRJbm9hS29hQllqQktObGtUTDZ6OHlRQ2F4ZGlNQzFRUlpNakd2MkdiU244N3hLX3lka3FHS3VoTlVtbzJ2LXk2UHJ0ckZ5VjdGUi1MSUFRaU5YX2kxb2tOUnJoUFItM256NTFaaHhRSlpFRjdNVWE1eEZmY3RzdW5LZmZGcmI4dEVaNFlWcmZFQ3RXRVhfaGctMVhYTm9pdVMyaUx4ZC1feDh1SGk2czRLRUJzaDQydWVlWUdQUFR6bzJ5c09PaUtCWFNoQQ?oc=5","date":"2025-02-26","type":"pipeline","source":"GlobeNewswire","summary":"DURYSTA’s Market Potential Across the 7MM is Set to Soar - GlobeNewswire","headline":"DURYSTA’s Market Potential Across the 7MM is Set to Soar","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}